中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer?s disease: diagnosis, longitudinal progress and biological basis

文献类型:期刊论文

作者Zhao, Kun1,3,4,20; Ding, Yanhui1; Han, Ying2,17,18,19; Fan, Yong5; Alexander-Bloch, Aaron F.6; Han, Tong7; Jin, Dan3,4,8; Liu, Bing3,4,8,9; Lu, Jie10; Song, Chengyuan11
刊名SCIENCE BULLETIN
出版日期2020-07-15
卷号65期号:13页码:1103-1113
ISSN号2095-9273
DOI10.1016/j.scib.2020.04.003
通讯作者Zhang, Xi(zhangxi@301.hospital.com.cn) ; Liu, Yong(yliu@nlpr.ia.ac.cn)
WOS关键词MILD COGNITIVE IMPAIRMENT ; POLYGENIC RISK ; MRI ; SHAPE ; ASSOCIATION ; DEMENTIA ; VOLUME ; CLASSIFICATION ; SEGMENTATION ; RELIABILITY
资助项目National Key Research and Development Program of China[2016YFC1305904] ; National Natural Science Foundation of China[81871438] ; National Natural Science Foundation of China[81901101] ; National Natural Science Foundation of China[61633018] ; National Natural Science Foundation of China[81571062] ; National Natural Science Foundation of China[81400890] ; National Natural Science Foundation of China[81871398] ; Chinese Academy of Sciences[XDB32020200] ; Beijing Municipal Science & Technology Commission[Z171100000117001] ; Beijing Municipal Science & Technology Commission[Z171100000117002] ; Primary Research & Development Plan of Shandong Province[2017GGX10112] ; National Laboratory of Pattern Recognition (NLPR)[201900021] ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)[U01 AG024904] ; DOD ADNI (Department of Defense)[W81XWH-12-2-0012] ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; AbbVie ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; BioClinica, Inc. ; Biogen ; Bristol-Myers Squibb Company ; CereSpir, Inc. ; Cogstate ; Eisai Inc. ; Elan Pharmaceuticals, Inc. ; Eli Lilly and Company ; EuroImmun ; F. Hoffmann-La Roche Ltd, and its affiliated company Genentech, Inc. ; Fujirebio ; GE Healthcare ; IXICO Ltd. ; Janssen Alzheimer Immunotherapy Research & Development, LLC ; Johnson & Johnson Pharmaceutical Research & Development LLC ; Lumosity ; Lundbeck ; Merck Co., Inc. ; Meso Scale Diagnostics, LLC ; NeuroRx Research ; Neurotrack Technologies ; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Piramal Imaging ; Servier ; Takeda Pharmaceutical Company ; Transition Therapeutics ; Canadian Institutes of Health Research
WOS研究方向Science & Technology - Other Topics
语种英语
出版者ELSEVIER
WOS记录号WOS:000542034100011
资助机构National Key Research and Development Program of China ; National Natural Science Foundation of China ; Chinese Academy of Sciences ; Beijing Municipal Science & Technology Commission ; Primary Research & Development Plan of Shandong Province ; National Laboratory of Pattern Recognition (NLPR) ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) ; DOD ADNI (Department of Defense) ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; AbbVie ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; BioClinica, Inc. ; Biogen ; Bristol-Myers Squibb Company ; CereSpir, Inc. ; Cogstate ; Eisai Inc. ; Elan Pharmaceuticals, Inc. ; Eli Lilly and Company ; EuroImmun ; F. Hoffmann-La Roche Ltd, and its affiliated company Genentech, Inc. ; Fujirebio ; GE Healthcare ; IXICO Ltd. ; Janssen Alzheimer Immunotherapy Research & Development, LLC ; Johnson & Johnson Pharmaceutical Research & Development LLC ; Lumosity ; Lundbeck ; Merck Co., Inc. ; Meso Scale Diagnostics, LLC ; NeuroRx Research ; Neurotrack Technologies ; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Piramal Imaging ; Servier ; Takeda Pharmaceutical Company ; Transition Therapeutics ; Canadian Institutes of Health Research
源URL[http://ir.ia.ac.cn/handle/173211/39945]  
专题自动化研究所_脑网络组研究中心
通讯作者Zhang, Xi; Liu, Yong
作者单位1.Shandong Normal Univ, Sch Informat Sci & Engn, Jinan 250358, Peoples R China
2.Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China
3.Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing 100190, Peoples R China
4.Chinese Acad Sci, Brainnetome Ctr, Inst Automat, Beijing 100190, Peoples R China
5.Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
6.Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA
7.Tianjin Huanhu Hosp, Dept Radiol, Tianjin 300350, Peoples R China
8.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100049, Peoples R China
9.Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Inst Automat, Beijing 100190, Peoples R China
10.Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing 100053, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Kun,Ding, Yanhui,Han, Ying,et al. Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer?s disease: diagnosis, longitudinal progress and biological basis[J]. SCIENCE BULLETIN,2020,65(13):1103-1113.
APA Zhao, Kun.,Ding, Yanhui.,Han, Ying.,Fan, Yong.,Alexander-Bloch, Aaron F..,...&Liu, Yong.(2020).Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer?s disease: diagnosis, longitudinal progress and biological basis.SCIENCE BULLETIN,65(13),1103-1113.
MLA Zhao, Kun,et al."Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer?s disease: diagnosis, longitudinal progress and biological basis".SCIENCE BULLETIN 65.13(2020):1103-1113.

入库方式: OAI收割

来源:自动化研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。